(Q36682671)

15 August 2017

1 reference

title

Abdominal obesity and metabolic syndrome (English)

1 reference

15 August 2017

0 references

1 reference

Jean-Pierre Després

1 reference

15 August 2017

Isabelle Lemieux

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

444

1 reference

15 August 2017

issue

7121

1 reference

15 August 2017

page(s)

881-887

1 reference

Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Does a diagnosis of metabolic syndrome have value in clinical practice?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic syndrome: a clinical and molecular perspective

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome: should current criteria influence clinical practice?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome: is this diagnosis necessary?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Is insulin resistance the cause of the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The myth of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome: requiescat in pace

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Paul Zimmet: fighting the "diabesity" pandemic

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Abdominal fat distribution and metabolic risk factors: effects of race

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Intraabdominal adipose tissue and anthropometric surrogates in African American women with upper- and lower-body obesity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Relationship between obesity, insulin resistance, and coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Is visceral obesity the cause of the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic implications of body fat distribution

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Regional adiposity and morbidity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Point: visceral adiposity is causally related to insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Extreme insulin resistance of the central adipose depot in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Why visceral fat is bad: mechanisms of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Adipose tissue, inflammation, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Molecular mechanisms of insulin resistance and the role of the adipocyte

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic syndrome: definition, pathophysiology, and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Mechanism of insulin resistance in A-ZIP/F-1 fatless mice

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Lipodystrophies: rare disorders causing metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Failure of adipocyte differentiation causes type II diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Diabetic macrovascular disease: the glucose paradox?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Hyperglycemia and cardiovascular disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Insulin resistance in human partial lipodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Cigarette smoking and increased central adiposity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Studies in the distribution of body fat. III. Effects of cigarette smoking

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Treatment of obesity: need to focus on high risk abdominally obese patients

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): Relationship to metabolic risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Response of blood lipids to exercise training alone or combined with dietary intervention

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Waist girth does not predict metabolic complications in severely obese men

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Waist circumference as a measure for indicating need for weight management.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

The response to long-term overfeeding in identical twins

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05488

7 January 2021

Identifiers

DOI

10.1038/NATURE05488

1 reference

15 August 2017

1 reference